Sphera Funds Management Ltd. Adc Therapeutics Sa Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 205,036 shares of ADCT stock, worth $416,223. This represents 0.12% of its overall portfolio holdings.
Number of Shares
205,036
Previous 685,547
70.09%
Holding current value
$416,223
Previous $2.17 Million
70.22%
% of portfolio
0.12%
Previous 0.32%
Shares
2 transactions
Others Institutions Holding ADCT
# of Institutions
80Shares Held
55.1MCall Options Held
82.7KPut Options Held
31.5K-
Redmile Group, LLC San Francisco, CA15.7MShares$31.8 Million3.23% of portfolio
-
Prosight Management, LP Dallas, TX9.64MShares$19.6 Million8.15% of portfolio
-
Orbimed Advisors LLC San Diego, CA4.53MShares$9.2 Million0.34% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$7.22 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$6.17 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $158M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...